Business Description
Ahn-Gook Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : KR7001540004
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 2.63 | |||||
Interest Coverage | 2.74 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.1 | |||||
3-Year EBITDA Growth Rate | 19.2 | |||||
3-Year FCF Growth Rate | 14 | |||||
3-Year Book Growth Rate | 0.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.24 | |||||
9-Day RSI | 50.21 | |||||
14-Day RSI | 48.12 | |||||
6-1 Month Momentum % | -7.14 | |||||
12-1 Month Momentum % | -19.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 134.56 | |||||
Days Sales Outstanding | 85.29 | |||||
Days Payable | 51.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.28 | |||||
Dividend Payout Ratio | 0.73 | |||||
Forward Dividend Yield % | 3.28 | |||||
5-Year Yield-on-Cost % | 3.26 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | -53.16 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.25 | |||||
Operating Margin % | 2.29 | |||||
Net Margin % | 5.4 | |||||
FCF Margin % | -26.44 | |||||
ROE % | 8.97 | |||||
ROA % | 5.18 | |||||
ROIC % | 1.94 | |||||
ROC (Joel Greenblatt) % | 14.62 | |||||
ROCE % | 11.46 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 5.36 | |||||
PE Ratio without NRI | 22.21 | |||||
PS Ratio | 0.29 | |||||
PB Ratio | 0.46 | |||||
Price-to-Tangible-Book | 0.47 | |||||
Price-to-Operating-Cash-Flow | 10.38 | |||||
EV-to-EBIT | 5.35 | |||||
EV-to-EBITDA | 4.11 | |||||
EV-to-Revenue | 0.46 | |||||
EV-to-FCF | -1.73 | |||||
Price-to-Median-PS-Value | 0.36 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.93 | |||||
Price-to-Graham-Number | 0.68 | |||||
Earnings Yield (Greenblatt) % | 18.69 | |||||
FCF Yield % | -91.34 | |||||
Forward Rate of Return (Yacktman) % | 0.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ahn-Gook Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 264,635.741 | ||
EPS (TTM) (â‚©) | 1257 | ||
Beta | 0.94 | ||
Volatility % | 25.4 | ||
14-Day RSI | 48.12 | ||
14-Day ATR (â‚©) | 161.575289 | ||
20-Day SMA (â‚©) | 6728.5 | ||
12-1 Month Momentum % | -19.04 | ||
52-Week Range (â‚©) | 6240 - 10160 | ||
Shares Outstanding (Mil) | 11.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ahn-Gook Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ahn-Gook Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Ahn-Gook Pharmaceutical Co Ltd Frequently Asked Questions
What is Ahn-Gook Pharmaceutical Co Ltd(XKRX:001540)'s stock price today?
When is next earnings date of Ahn-Gook Pharmaceutical Co Ltd(XKRX:001540)?
Does Ahn-Gook Pharmaceutical Co Ltd(XKRX:001540) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |